Effects of verocytotoxin-1 on nonadherent human monocytes: Binding characteristics, protein synthesis, and induction of cytokine release

Blood

Volumn 88, Issue 1, 1996, Pages 174-183

  Van Setten, Petra A ^b   Monnens, Leo A H ^b   Verstraten, Riet G G ^b   Van Den Heuvel, Lambert P W J ^b   Van Hinsbergh, Victor W M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLOBOTRIAOSYLCERAMIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; GLOMERULUS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029957125     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.174.174     Document Type: Article

References (51)

1. Fong JS, De Chadarevian JP, Kaplan BS: Hemolytic uremic syndrome. Current concepts and management. Pediatr Clin North Am 29:835, 1982
2. Karmali MA, Petric M, Lim C, Fleming DC, Arbus GS, Lior H: The association between idiopathic hemolytic syndrome and infection by verocytotoxin producing Escheriachia coli. J Infect Dis 151:775, 1985
3. Remuzzi G: HUS and TTP: Variable expression of a single entity [clinical conference]. Kidney Int 32:292, 1987
4. Richardson SE, Karmali MA, Becker LE, Smith CR: The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 19:1102, 1988
5. Argyle JC, Hogg RJ, Pysher TJ, Silva FG, Siegler RL: A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 4:52, 1990
6. Barrett TJ, Potter ME, Strockbine NA: Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice. Microb Pathog 9:95, 1990
7. Harel Y, Silva M, Giroir B, Weinberg A, Cleary TB, Beutler B: A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. J Clin Invest 92:2110, 1993
8. Tesh VL, Ramegowda B, Samuel JE: Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun 62:5085, 1994
9. Tesh VL, Samuel JE, Perera LP, Sharefkin JB, O'Brien AD: Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 164:344, 1991
10. Louise CB, Obrig TG: Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 59:4173, 1991
11. van de Kar NC, Monnens LA, Karmali MA, van Hinsbergh VW: Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755, 1992
12. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 70:427, 1990
13. Lamas S, Michel T, Brenner BM, Marsden PA: Nitric oxide synthesis in endothelial cells: Evidence for a pathway inducible by TNF-alpha. Am J Physiol 261:C634, 1991
14. Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89:7384, 1992
15. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S. Minami N, Takahashi H, Deguchi K, Nakano T, Shirakawa S: Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol 40:167, 1992
16. Karpman D, Andreasson A, Thysell H, Kaplan BS, Svanborg C: Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nephrol 9:694, 1995
17. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM: Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42:951, 1992
18. Van de Kar NCAJ, Sauerwein RW, Demacker PNM, Grau GE, Van Hinsbergh VWM, Monnens LAH: Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71:309, 1995
19. Siegler RL, Edwin SS, Christofferson RD, Mitchell MD: Plasma and urinary cytokines in childhood hemolytic urmemic syndrome. J Am Soc Nephrol 2:274, 1991
20. Johnston RBJ: Current concepts: Immunology. Monocytes and macrophages. N Engl J Med 318:747, 1988
21. Obrig TG, Moran TP, Brown JE: The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J 244:287, 1987
22. Petric M, Karmali MA, Richardson SE, Chung R: Purification and biological properties of Escherichia coli verocytotoxin-1. FEMS Microbiol Lett 41:63, 1987
23. Nudelman E, Kannagi R, Hakomori S, Parsons M, Lipinski M, Wiels J, Fellous M, Tursz T: A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220:509, 1983
24. De Mulder PH, Wessels JM, Rosenbrand DA, Smeulders JB, Wagener DJ, Haanen C: Monocyte purification with counterflow centrifugation monitored by continuous flow cytometry. J Immunol Methods 47:31, 1981
25. van der Meer JW, Bulterman D, van-Zwet TL, Elzenga-Claasen I, van-Furth R: Culture of mononuclear phagocytes on a teflon surface to prevent adherence. J Exp Med 147:271, 1978
26. van der Meer JW, van-de-Gevel JS, Elzenga-Claassen I, vanFurth R: Suspension cultures of mononuclear phagocytes in the teflon culture bag. Cell Immunol 42:208, 1979
27. Salacinski PR, McLean C, Sykes JE, Clement-Jones VV, Lowry PJ: Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem 117:136, 1981
28. Calvo JC, Radicella JP, Charreau EH: Measurement of specific radioactivities in labelled hormones by self-displacement analysis. Biochem J 212:259, 1983
29. Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De-Grandis S, Karmali M: Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262:8834, 1987
30. van der Meer JW, Endres S, Lonnemann G, Cannon JG, Ikejima T, Okusawa S, Gelfand JA, Dinarello CA: Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol 43:216, 1988
31. Lisi PJ, Chu CW, Koch GA, Endres S, Lonnemann G, Dinarello CA: Development and use of a radioimmunoassay for human interleukin-1 beta. Lymphokine Res 6:229, 1987
32. Barrera P, Boerbooms AM, Janssen EM, Sauerwein RW, Gallati H, Mulder J, de-Boo T, Demacker PN, van-de-Putte LB, vander-Meer JW: Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 36:1070, 1993
33. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
34. Bouaboula M, Legoux P, Pessegue B, Delpech B, Dumont X, Piechaczyk M, Casellas P, Shire D: Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem 267:21830, 1992
35. Moran T, Lingwood C, Branca A, Del Vecchio P, Brown J, Obrig T: Analysis of shiga toxin receptors on human vascular endothelial cells. Abstract Annual Meeting of the American Society of Microbiology, New Orleans, LA, May 14-18, 1989, 46:B93
36. Cohen A, Madrid-Marina V, Estrov Z, Freedman MH, Lingwood CA, Dosch HM: Expression of glycolipid receptors to Shigalike toxin on human B lymphocytes: A mechanism for the failure of long-lived antibody response to dysenteric disease. Int Immunol 2:1, 1990
37. Boyd B, Lingwood C: Verotoxin receptor glycolipid in human renal tissue [published erratum appears in Nephron 51:582, 1989]. Nephron 51:207, 1989
38. Obrig TG, Del-Vecchio PJ, Karmali MA, Petric M, Moran TP, Judge TK: Pathogenesis of haemolytic uraemic syndrome [letter]. Lancet 2:687, 1987
39. Kavi J, Chant I, Maris M, Rose PE: Cytopathic effect of verotoxin on endothelial cells [letter]. Lancet 2:1035, 1987
40. Barrett TJ, Potter ME, Wachsmuth IK: Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun 57:3434, 1989
41. Barret TJ, Potter ME, Wachsmuth IK: Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases. J Infect Dis 159:774, 1989
42. Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG: Shiga toxin-associated hemolytic uremic syndrome: Interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun 61:3886, 1993
43. Louise CB, Obrig TG: Shiga toxin-associated hemolytic uremic syndrome: Combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60:1536, 1992
44. Chart H, Scotland SM, Smith HR, Rowe B: Antibodies to Escherichia coli 0157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. J Clin Pathol 42:973, 1989
45. Kiarash A, Boyd B, Lingwood CA: Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J Biol Chem 269:11138, 1994
46. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT: Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 163:1391, 1986
47. Khine AA, Lingwood CA: Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin). 1 : Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization. J Cell Physiol 161:319, 1994
48. Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, van-Deurs B: Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358:510, 1992
49. Anderson RG: Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90:10909, 1993
50. Jacewicz MS, Mobassaleh M, Gross SK, Balasubramanian KA, Daniel PF, Raghavan S, McCluer RH, Keusch GT: Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J Infect Dis 169:538, 1994
51. Cotran RS, Pober JS: Effects of cytokines on vascular endothelium: Their role in vascular and immune injury. Kidney Int 35:969, 1989